Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function
Article in European Journal of Pharmacology (April 2023)
The most recent citing publications are shown below. View all 60 publications that cite this research output on Dimensions.
Article in European Journal of Pharmacology (April 2023)
Article in Clinical Pharmacology & Therapeutics (January 2023)
Article in Hormones (September 2022)